(PharmaNewsWire.Com, September 17, 2017 ) Coccidiosis, a parasitic infection of the intestinal tract of animals is caused by coccidian protozoa. The disease feasts from one animal to another by any contact with infected faeces or consumption of infected tissue. It infects a wide variety of animals, such as cattle, poultry species, pigs and sheep. It can be responsible for devastating mislay in meat production. To overcome this problem, anticoccidial drugs play an important role in the prevention and treatment of coccidiosis.
The ban on consumption of antibiotics as a source of animal feed and the upsurge in incidences of antibiotic microbes has seen a reduced growth in the antibiotic Industry, nevertheless the rising incidence of coccidiosis over the preceding 50 years and its control on the overall cost to benefit ratio for the meat industry has furthered the anticoccidials drug Industry.
Growing demand for meat proteins are increasing usage of anticoccidial drugs and are the driving force for global anticoccidial drugs Industry. Besides, less stringent regulations and increased expenditure on companion animals are also assistant in growth of global anticoccidial drugs Industry. Further, the trend of owning companion animals is causative to the growing usage of anticoccidials in developing regions.
The global anticoccidial drugs Industry is classified based on various types of animals and by type of drugs. The animal segment is further sub-categorised into poultry, swine, fish, cattle and companion animals. The companion animal further includes dogs and cats. The drug segment includes antibiotic anticoccidials, Ionophore anticoccidials and chemical derivative anticoccidials. Furthermore, based on geography the Industry is segmented into various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
North America dominates the global anticoccidial drugs Industry owing to preventive usage of anticoccidials in animal feed. Its countries combined contribute around 24% of the worldwide Industry for anticoccidial drugs. The U.S. holds the largest Industry share for anticoccidial drugs followed by Mexico and Canada in North America. Germany, France, Spain and U.K holds major share of the European anticoccidial drugs Industry
The industry is and will remain to face diverse challenges related to microbial resistance build-up and government regulations in US and Europe, consequently the major players will be focusing on the not as much of regulated Industrys in the South America and Asia Pacific regions. These being the regions estimated to grow the most during the forecasted period.
Some of the few key players operating in the Industry are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santι Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc.
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
